GlaxoSmithKline PLC (GSK) — Strategic Asset Allocation Index
GlaxoSmithKline PLC (GSK) has a Strategic Asset Allocation Index of 83.2% as of March 2023. Strategic assets (PP&E of GBX9.41 Billion plus long-term investments of GBX-) total GBX9.41 Billion, measured against net assets of GBX11.31 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of GlaxoSmithKline PLC to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
GlaxoSmithKline PLC Strategic Asset Allocation Index (2000–2022)
This chart shows how GlaxoSmithKline PLC's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of March 2023, the index stands at 83.2%, representing strategic assets of GBX9.41 Billion against net assets of GBX11.31 Billion GBX. For live market cap and overall valuation, see how much is GlaxoSmithKline PLC worth.
Annual Strategic Asset Allocation Index for GlaxoSmithKline PLC (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GlaxoSmithKline PLC from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See GlaxoSmithKline PLC shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 95.3% | GBX9.62 Billion | GBX9.62 Billion | GBX- | GBX10.10 Billion | ▲ +45.3 pp |
| 2021 | 50.0% | GBX10.67 Billion | GBX10.67 Billion | GBX- | GBX21.34 Billion | ▼ -2.9 pp |
| 2020 | 52.9% | GBX11.01 Billion | GBX11.01 Billion | GBX- | GBX20.81 Billion | ▼ -20.5 pp |
| 2019 | 73.4% | GBX13.47 Billion | GBX11.31 Billion | GBX2.16 Billion | GBX18.36 Billion | ▼ -270.3 pp |
| 2018 | 343.7% | GBX12.62 Billion | GBX11.06 Billion | GBX1.56 Billion | GBX3.67 Billion | ▲ +0.7 pp |
| 2017 | 343.0% | GBX11.97 Billion | GBX10.86 Billion | GBX1.11 Billion | GBX3.49 Billion | ▲ +100.1 pp |
| 2016 | 242.9% | GBX12.06 Billion | GBX10.81 Billion | GBX1.25 Billion | GBX4.96 Billion | ▲ +117.6 pp |
| 2015 | 125.4% | GBX11.13 Billion | GBX9.67 Billion | GBX1.46 Billion | GBX8.88 Billion | ▼ -87.5 pp |
| 2014 | 212.8% | GBX10.51 Billion | GBX9.05 Billion | GBX1.45 Billion | GBX4.94 Billion | ▲ +79.7 pp |
| 2013 | 133.1% | GBX10.40 Billion | GBX8.87 Billion | GBX1.53 Billion | GBX7.81 Billion | ▲ +3.0 pp |
| 2012 | 130.1% | GBX8.78 Billion | GBX8.78 Billion | GBX- | GBX6.75 Billion | ▲ +31.0 pp |
| 2011 | 99.1% | GBX8.75 Billion | GBX8.75 Billion | GBX- | GBX8.83 Billion | ▲ +6.3 pp |
| 2010 | 92.8% | GBX9.04 Billion | GBX9.04 Billion | GBX- | GBX9.74 Billion | ▲ +5.6 pp |
| 2009 | 87.3% | GBX9.37 Billion | GBX9.37 Billion | GBX- | GBX10.74 Billion | ▼ -29.1 pp |
| 2008 | 116.4% | GBX9.68 Billion | GBX9.68 Billion | GBX- | GBX8.32 Billion | ▲ +37.4 pp |
| 2007 | 78.9% | GBX7.82 Billion | GBX7.82 Billion | GBX- | GBX9.91 Billion | ▲ +7.1 pp |
| 2006 | 71.8% | GBX6.93 Billion | GBX6.93 Billion | GBX- | GBX9.65 Billion | ▼ -16.0 pp |
| 2005 | 87.9% | GBX6.65 Billion | GBX6.65 Billion | GBX- | GBX7.57 Billion | ▼ -21.1 pp |
| 2004 | 109.0% | GBX6.47 Billion | GBX6.47 Billion | GBX- | GBX5.94 Billion | ▲ +0.9 pp |
| 2003 | 108.0% | GBX6.27 Billion | GBX6.27 Billion | GBX- | GBX5.80 Billion | ▲ +20.2 pp |
| 2002 | 87.8% | GBX6.49 Billion | GBX6.49 Billion | GBX- | GBX7.39 Billion | ▲ +8.8 pp |
| 2001 | 79.1% | GBX6.64 Billion | GBX6.64 Billion | GBX- | GBX8.40 Billion | ▲ +4.9 pp |
| 2000 | 74.2% | GBX6.64 Billion | GBX6.64 Billion | GBX- | GBX8.96 Billion | — |